CIK: 0001306923 · Show all filings
Period: Q4 2015 (← Previous) (Next →)
Filing Date: Feb 16, 2016
Total Value ($000): $1,796,692 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ABIOMED INC | 2,889,505 | $260,865 | 14.5% | $29.48 | — | COM | 003654100 |
| — | ANACOR PHARMACEUTICALS INC | 2,187,242 | $247,093 | 13.8% | $23.70 | — | COM | 032420101 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 1,518,654 | $237,836 | 13.2% | $81.75 | +78.1% | COM | 91307C102 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,336,847 | $140,048 | 7.8% | $73.11 | +42.7% | COM | 09061G101 |
| — | CLOVIS ONCOLOGY INC | 3,547,719 | $124,170 | 6.9% | $57.85 | — | COM | 189464100 |
| INSM | INSMED INC | 4,790,800 | $86,953 | 4.8% | $14.79 | +19.1% | COM PAR $.01 | 457669307 |
| — | AMAG PHARMACEUTICALS INC | 2,835,792 | $85,613 | 4.8% | $30.99 | — | COM | 00163U106 |
| — | WRIGHT MED GROUP N V | 2,132,157 | $51,556 | 2.9% | $24.18 | — | ORD SHS 0.03 PAR | N96617118 |
| — | ENDO INTL PLC | 801,230 | $49,051 | 2.7% | $89.70 | — | SHS | G30401106 |
| PRTA | PROTHENA CORP PLC | 695,518 | $47,372 | 2.6% | $22.18 | +171.9% | SHS | G72800108 |
| — | EPIZYME INC | 2,660,979 | $42,629 | 2.4% | $13.76 | — | COM | 29428V104 |
| — | KARYOPHARM THERAPEUTICS INC | 3,112,645 | $41,243 | 2.3% | $20.94 | — | COM | 48576U106 |
| VNDA | VANDA PHARMACEUTICALS INC | 4,030,908 | $37,528 | 2.1% | $8.48 | +17.7% | COM | 921659108 |
| — | CEMPRA INC | 1,175,733 | $36,601 | 2.0% | $31.13 | — | COM | 15130J109 |
| FOLD | AMICUS THERAPEUTICS INC | 3,551,173 | $34,446 | 1.9% | $5.71 | +57.8% | COM | 03152W109 |
| — | CELGENE CORP | 270,800 | $32,431 | 1.8% | $97.13 | — | COM | 151020104 |
| GILD | GILEAD SCIENCES INC | 302,900 | $30,650 | 1.7% | $63.23 | +15.3% | COM | 375558103 |
| — | MEDIVATION INC | 509,862 | $24,647 | 1.4% | $58.10 | — | COM | 58501N101 |
| — | MOMENTA PHARMACEUTICALS INC | 1,468,776 | $21,797 | 1.2% | $14.44 | — | COM | 60877T100 |
| — | SHIRE PLC | 104,700 | $21,464 | 1.2% | $227.87 | — | SPONSORED ADR | 82481R106 |
| STAA | STAAR SURGICAL CO | 2,666,722 | $19,040 | 1.1% | $8.11 | -0.1% | COM PAR $0.01 | 852312305 |
| — | SEQUENOM INC | 10,023,842 | $16,439 | 0.9% | $3.91 | — | COM NEW | 817337405 |
| — | ZELTIQ AESTHETICS INC | 573,636 | $16,366 | 0.9% | $26.16 | — | COM | 98933Q108 |
| — | RIGEL PHARMACEUTICALS INC | 5,239,119 | $15,875 | 0.9% | $3.43 | — | COM NEW | 766559603 |
| — | ARIAD PHARMACEUTICALS INC | 2,257,217 | $14,108 | 0.8% | $6.81 | — | COM | 04033A100 |
| — | HEARTWARE INTL INC | 246,068 | $12,402 | 0.7% | $87.77 | — | COM | 422368100 |
| — | ALIMERA SCIENCES INC | 3,013,793 | $7,293 | 0.4% | $4.88 | — | COM | 016259103 |
| — | SUNESIS PHARMACEUTICALS INC | 6,974,854 | $6,260 | 0.3% | $1.05 | — | COM NEW | 867328601 |
| — | AIMMUNE THERAPEUTICS INC | 325,599 | $6,007 | 0.3% | $25.32 | — | COM | 00900T107 |
| — | ACELRX PHARMACEUTICALS INC | 1,425,439 | $5,488 | 0.3% | $5.78 | — | COM | 00444T100 |
| — | IDERA PHARMACEUTICALS INC | 1,257,748 | $3,886 | 0.2% | $3.70 | — | COM NEW | 45168K306 |
| EXAS | EXACT SCIENCES CORP | 396,276 | $3,658 | 0.2% | $12.83 | -27.5% | COM | 30063P105 |
| — | DICERNA PHARMACEUTICALS INC | 267,890 | $3,180 | 0.2% | $9.72 | — | COM | 253031108 |
| — | OREXIGEN THERAPEUTICS INC | 1,673,024 | $2,878 | 0.2% | $6.46 | — | COM | 686164104 |
| ALGN | ALIGN TECHNOLOGY INC | 27,757 | $1,828 | 0.1% | $53.35 | +20.3% | COM | 016255101 |
| — | ALCOBRA LTD | 254,188 | $1,596 | 0.1% | $6.09 | — | SHS | M2239P109 |
| — | HISTOGENICS CORP | 454,545 | $1,591 | 0.1% | $11.00 | — | COM | 43358V109 |
| — | INTREXON CORP | 47,100 | $1,420 | 0.1% | $28.82 | — | COM | 46122T102 |
| CYTK | CYTOKINETICS INC | 123,686 | $1,294 | 0.1% | $6.71 | +46.1% | COM NEW | 23282W605 |
| — | SOPHIRIS BIO INC | 494,000 | $879 | 0.0% | $2.60 | — | COM NEW | 83578Q209 |
| — | MARINUS PHARMACEUTICALS INC | 59,017 | $451 | 0.0% | $8.34 | — | COM | 56854Q101 |
| — | ZOGENIX INC | 28,600 | $422 | 0.0% | $13.52 | — | COM NEW | 98978L204 |
| QURE | UNIQURE NV | 20,453 | $338 | 0.0% | $26.34 | -29.7% | SHS | N90064101 |